Page last updated: 2024-11-03

probenecid and Gelineau Syndrome

probenecid has been researched along with Gelineau Syndrome in 3 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faull, KF1
Barchas, JD2
Foutz, AS2
Dement, WC3
Holman, RB2
Guilleminault, C1
Phillips, R1
Faull, K1

Other Studies

3 other studies available for probenecid and Gelineau Syndrome

ArticleYear
Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs.
    Brain research, 1982, Jun-17, Volume: 242, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Dogs; Homovanillic Acid; Humans; Hydroxyin

1982
A syndrome of hypersomnia with automatic behavior.
    Electroencephalography and clinical neurophysiology, 1975, Volume: 38, Issue:4

    Topics: Adult; Attention; Automatism; Circadian Rhythm; Electroencephalography; Homovanillic Acid; Humans; H

1975
The concentrations of amine metabolites in cerebrospinal fluid from normal and narcoleptic dogs [proceedings].
    The Journal of physiology, 1979, Volume: 296

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dogs; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid;

1979